person · Reporting owner
BlueLine Capital Partners II, L.P.
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CYANOTECH CORPCYAN · Entity 8431 | 10% owner | November 07, 2018 | November 09, 2018 |
| IRIDEX CORPIRIX · Entity 7882 | 10% owner | November 21, 2017 | November 22, 2017 |
| InfuSystem Holdings, IncINFU · Entity 6163 | Director | December 07, 2020 | December 09, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CYANOTECH CORP
Report date November 07, 2018 · Filed November 09, 2018
Jointly reported with Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Partners, L.L.C.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 850,116 |
Reported balance
After 2018-11-07 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2018-11-07 · Other · Acquired 100,506 · Balance 850,116 F1: These securities are owned by Meridian TSV II, LP. The shares were contributed to that entity by a limited partner in such entity. F2: As described in the Schedule 13D filing made on May 9, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are owned by Meridian TSV II, LP. The shares were contributed to that entity by a limited partner in such entity.
F2: As described in the Schedule 13D filing made on May 9, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.
IRIDEX CORP
Report date November 21, 2017 · Filed November 22, 2017
Jointly reported with BlueLine Capital Partners, L.P., BlueLine Capital Partners III, LP, BlueLine Partners, L.L.C., BlueLine Partners II, LLC, BlueLine Catalyst Fund IX, L.P.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,138,862 |
Reported balance
After 2017-11-21 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2017-11-21 · Other · Disposed 267,631 · Balance 1,138,862 F1: These securities were owned by BlueLine Capital Partners III, L.P. On November 21, 2017, BlueLine Capital Partners III, L.P. executed an in-kind distribution, without consideration, of 267,631 shares of the Issuer's common stock to certain of its limited partners. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement. F2: As described in Amendment No. 4 to Schedule 13D ("Amendment No. 4") filed on October 25, 2007 with respect to the securities owned by BlueLine Capital Partners, L.P., BlueLine Capital Partners II, L.P., BlueLine Capital Partners III, L.P., BlueLine Catalyst Fund VIII, L.P., BlueLine Catalyst Fund IX, L.P., BlueLine Partners, L.L.C., and BlueLine Partners II, L.L.C., as of the date of Amendment No. 4, the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Entity may have been deemed to have beneficial ownership of 10% or more of the securities. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities were owned by BlueLine Capital Partners III, L.P. On November 21, 2017, BlueLine Capital Partners III, L.P. executed an in-kind distribution, without consideration, of 267,631 shares of the Issuer's common stock to certain of its limited partners. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement.
F2: As described in Amendment No. 4 to Schedule 13D ("Amendment No. 4") filed on October 25, 2007 with respect to the securities owned by BlueLine Capital Partners, L.P., BlueLine Capital Partners II, L.P., BlueLine Capital Partners III, L.P., BlueLine Catalyst Fund VIII, L.P., BlueLine Catalyst Fund IX, L.P., BlueLine Partners, L.L.C., and BlueLine Partners II, L.L.C., as of the date of Amendment No. 4, the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Entity may have been deemed to have beneficial ownership of 10% or more of the securities. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement.
InfuSystem Holdings, Inc
Report date December 07, 2020 · Filed December 09, 2020
Jointly reported with Meridian OHC LLC, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Partners, L.L.C.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 493,656 |
Last balance in matching sequence
After 2020-12-09 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2020-12-07 · Sale · Disposed 2,900 · Balance 499,850 F1: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Row 2 · 2020-12-08 · Sale · Disposed 4,489 · Balance 495,361 F1: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Row 3 · 2020-12-09 · Sale · Disposed 1,705 · Balance 493,656 F1: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 24, 2017 Filed Aug 25, 2017 17:54 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 155 | $1.80 | $279.00 |
DisclosureSEC source: 0001445866-17-001277 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,740,610 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 23, 2017 Filed Aug 25, 2017 17:54 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 2,166 | $1.80 | $3,898.80 |
DisclosureSEC source: 0001445866-17-001277 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,740,455 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 16, 2017 Filed Aug 16, 2017 18:44 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 26,670 | $1.80 | $48,006.00 |
DisclosureSEC source: 0001445866-17-001234 · form4.xml · nonDerivative · entry 3 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,738,289 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 16, 2017 Filed Aug 16, 2017 18:44 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 15,000 | $1.85 | $27,750.00 |
DisclosureSEC source: 0001445866-17-001234 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,711,619 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 14, 2017 Filed Aug 16, 2017 18:44 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 15,000 | $1.90 | $28,500.00 |
DisclosureSEC source: 0001445866-17-001234 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,696,619 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 22, 2017 Filed Jun 23, 2017 23:25 UTC | IRIDEX CORP IRIX · Entity 7882 | OtherCommon Stock | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001445866-17-000922 · form4.xml · nonDerivative · entry 1 BlueLine Capital Partners, L.P. · CIK 0001338149 · 10% owner BlueLine Catalyst Fund IX, L.P. · CIK 0001460518 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Capital Partners III, LP · CIK 0001411986 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner BlueLine Partners II, LLC · CIK 0001411987 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,460,688 F1 · ownership.direct: These securities were owned by BlueLine Capital Partners, L.P. On June 22, 2017, BlueLine Capital Partners, L.P. executed an in-kind distribution, without consideration, of 600,000 shares of the Issuer's common stock to certain of its limited partners. Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 17:29 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 109 | $1.50 | $163.50 |
DisclosureSEC source: 0001445866-17-000838 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,681,619 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 17:29 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 10,000 | $1.55 | $15,500.00 |
DisclosureSEC source: 0001445866-17-000838 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,681,510 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 02, 2017 Filed Jun 2, 2017 17:39 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 100 | $1.50 | $150.00 |
DisclosureSEC source: 0001445866-17-000809 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,671,510 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 02, 2017 Filed Jun 2, 2017 17:39 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 10,000 | $1.55 | $15,500.00 |
DisclosureSEC source: 0001445866-17-000809 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,671,410 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 25, 2017 Filed May 26, 2017 17:34 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 5,000 | $1.55 | $7,750.00 |
DisclosureSEC source: 0001445866-17-000793 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,666,410 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 24, 2017 Filed May 26, 2017 17:34 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 1,105 | $1.55 | $1,712.75 |
DisclosureSEC source: 0001445866-17-000793 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,661,410 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 16, 2016 Filed Dec 16, 2016 17:36 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 41,717 | $2.35 | $98,034.95 |
DisclosureSEC source: 0001445866-16-003003 · form4.xml · nonDerivative · entry 4 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,651,972 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 16, 2016 Filed Dec 16, 2016 17:36 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 35,100 | $2.30 | $80,730.00 |
DisclosureSEC source: 0001445866-16-003003 · form4.xml · nonDerivative · entry 3 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,610,255 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 15, 2016 Filed Dec 16, 2016 17:36 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 100,000 | $2.35 | $235,000.00 |
DisclosureSEC source: 0001445866-16-003003 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,575,155 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 15, 2016 Filed Dec 16, 2016 17:36 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 23,183 | $2.30 | $53,320.90 |
DisclosureSEC source: 0001445866-16-003003 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,475,155 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.